AIA
CBPO

AGF Investments America’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

AGF Investments America’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-12,230
Closed -$1.42M – 80
2019
Q4 		$1.42M Buy
12,230
+107
+0.9% +$12.4K 0.47% 50
2019
Q3 		$1.39M Buy
+12,123
New +$1.21M 0.46% 49

Other funds holding CBPO

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.38% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

AGF Investments America's CBPO Position: Q1 2020 in Review

AGF Investments America sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2020, closing a stake of 12,230 shares — an estimated $1.42M sold.

AGF Investments America first reported a position in CBPO in Q3 2019 and held it in 2 quarters. The position peaked at $1.42M in Q4 2019. 84 funds tracked by Wall St. Rank hold CBPO as of Q1 2020.

  • AGF Investments America reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2020 after selling out during the quarter.
  • AGF Investments America sold 12,230 China Biologic Products Holdings, Inc. shares in Q1 2020, an estimated $1.42M.
  • AGF Investments America first reported a position in China Biologic Products Holdings, Inc. in Q3 2019 and held it in 2 quarters.
  • AGF Investments America's China Biologic Products Holdings, Inc. position peaked at $1.42M in Q4 2019.
  • 84 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2020.

Based on AGF Investments America's 13F filing for Q1 2020, filed 8 May 2020.